Inventor
KHATUYA HARIPADA
US28 patents
⚠️ This page may combine multiple inventors who share the name “KHATUYA HARIPADA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
14 patentsUS9782408B2Oct 10, 2017
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA33 citations97
US10793547B2Oct 6, 2020
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA24 citations93
US10758534B2Sep 1, 2020
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA13 citations93
US10570115B2Feb 25, 2020
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA23 citations93
US10258624B2Apr 16, 2019
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA32 citations93
US11426407B2Aug 30, 2022
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA6 citations85
US11453655B2Sep 27, 2022
Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA8 citations84
US11186566B2Nov 30, 2021
Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA10 citations84
US11066417B2Jul 20, 2021
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
VERTEX PHARMA13 citations84
US11414439B2Aug 16, 2022
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA6 citations74
US11866450B2Jan 9, 2024
Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
VERTEX PHARMA3 citations73
US12168009B2Dec 17, 2024
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA1 citations72
US10738030B2Aug 11, 2020
Modulators of cystic fibrosis transmembrane conductance regulator
VERTEX PHARMA6 citations71
US12384762B2Aug 12, 2025
Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
VERTEX PHARMA0 citations61
ORTHO MCNEIL PHARM INC
12 patentsUS7309703B2Dec 18, 2007
Substituted pyrazoles
ORTHO MCNEIL PHARM INC15 citations92
US6583155B2Jun 24, 2003
Method for treating allergies using substituted pyrazoles
ORTHO MCNEIL PHARM INC15 citations92
US6803362B2Oct 12, 2004
Heterocyclic compounds
ORTHO MCNEIL PHARM INC38 citations91
US6384035B1May 7, 2002
Heterocycles useful in the treatment of benign prostatic hyperplasia
ORTHO MCNEIL PHARM INC18 citations91
US7772236B2Aug 10, 2010
Substituted pyrazoles
ORTHO MCNEIL PHARM INC9 citations84
US7393850B2Jul 1, 2008
Substituted pyrazoles
ORTHO MCNEIL PHARM INC3 citations73
US6953793B2Oct 11, 2005
Substituted pyrazoles
ORTHO MCNEIL PHARM INC11 citations73
US7417046B2Aug 26, 2008
Substituted pyrazoles
ORTHO MCNEIL PHARM INC1 citations62
US7589202B2Sep 15, 2009
Substituted pyrazoles
ORTHO MCNEIL PHARM INC0 citations52
US7452890B2Nov 18, 2008
Substituted pyrazoles
ORTHO MCNEIL PHARM INC0 citations52
US7429591B2Sep 30, 2008
Substituted pyrazoles
ORTHO MCNEIL PHARM INC0 citations52
US7388011B2Jun 17, 2008
Substituted pyrazoles
ORTHO MCNEIL PHARM INC0 citations52